Syria's Captagon Tablet Production Disrupted Following Regime Change, UNODC Reports
One year after the regime change in Syria, the country's illicit production of the synthetic stimulant captagon has been significantly disrupted, according to a UNODC research brief. Since December 2024, Syrian authorities have dismantled 15 large industrial-level laboratories and 13 smaller storage facilities linked to captagon manufacturing. This marks a substantial hit to one of the region's largest synthetic drug production hubs.
Before the regime change, Syria’s daily captagon output was estimated to reach millions of tablets, fueling drug trafficking and conflict economics across the Middle East. The shutdown of these facilities disrupts supply chains vital for organized crime networks, though the manufacturing of captagon outside Syria within the Middle East likely continues.
The UNODC could not confirm earlier assumptions that Syria’s production simply moved to other continents such as Africa. However, the drug’s persistence underlines ongoing challenges for regional security and law enforcement. The disruption may alter illicit drug flows and pressure traffickers to seek alternative markets or production sites.
This development is crucial for regional stability as captagon has been linked to financing armed groups and exacerbating violence. The research findings highlight the evolving synthetic drug market in Arab countries and the need for continued international cooperation to monitor and counter drug production and trafficking.
